Pre-made Ustekinumab benchmark antibody ( Whole mAb, anti-IL12B therapeutic antibody, Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-605

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-605 Category Tag

Product Details

Pre-Made Ustekinumab biosimilar, Whole mAb, Anti-IL12B Antibody: Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Ustekinumab, sold under the brand name Stelara?, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn’s disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis, targeting both IL-12 and IL-23.

Products Name (INN Index)

Pre-Made Ustekinumab biosimilar, Whole mAb, Anti-IL12B Antibody: Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 therapeutic antibody

INN Name

Ustekinumab

Target

IL12B

Format

Whole mAb

Derivation

Human

Species Reactivity

Human

CH1 Isotype

IgG1

VD LC

Kappa

Highest_Clin_Trial (Jan '20)

Approved

Est. Status

Active

100% SI Structure

3hmw:HL/3hmx:HL

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2008

Companies

Centocor Inc,Janssen Biotech,Medarex

Conditions Approved

Crohn's disease,Plaque psoriasis,Psoriatic arthritis

Conditions Active

Ulcerative colitis,Spondylarthritis,Systemic lupus erythematosus,Atopic dermatitis

Conditions Discontinued

Multiple sclerosis,Palmoplantar pustulosis,Primary biliary cirrhosis,Rheumatoid arthritis,Sarcoidosis

Development Tech

Medarex UltiMAb Mouse

Previous Name

NA

Gm Offical Target Name

IL12B

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide